Submission form: Formulation characteristics of therapeutic broad-spectrum sunscreen

Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.
The WHO Department of Medicines and Health Products Policies and Standards is calling for contributions from relevant stakeholders to help define optimal formulation characteristics for therapeutic broad-spectrum sunscreen for people with albinism and to identify the most appropriate formulations for potential inclusion on the WHO Model Lists of Essential Medicines.

The WHO Department of Medicines and Health Products Policies and Standards is calling for contributions from relevant stakeholders to help define optimal formulation characteristics for therapeutic broad-spectrum sunscreen for people with albinism and to identify the most appropriate formulations for potential inclusion on the WHO Model Lists of Essential Medicines.

Thank you for taking part.

There are 12 questions in this survey.
 
Close